Toggle navigation
Home
Search
Services
Blog
Contact
About
Innovative Therapies for Rheumatic and Skin Diseases-N01AR2226
University of Cincinnati, Cincinnati, OH, United States
Search grants from University of Cincinnati
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Targets for the Vhl Tumor Suppressor in Renal Cancer
Improved Noninvasive Pediatric Blood Pressure Method
I-Corps: Commercialization of a Novel, Low-Energy Homogenizer Technology for Algal Oil Extraction
CDI-Type II: Quantum Cyberinfrastructure for the Simulation of Complex Quantum Systems
RIA: Rapid System Prototyping Through Increased Subsystem Reusability
Recently added grants:
Unveiling the Oncogenic Roles of ADAM10/17 by Comprehensively Profiling Proteolytic Activity on a Synthetic Human Protein Peptide Phage Library
Regulation of lung cancer growth and metastasis by an actionable driver of vesicle biogenesis in the Golgi
Synergistic Targeted Therapy of Antibody-Drug Conjugates for Triple-Negative Breast Cancer
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
Targeting the Circadian Rhythm in Glioblastoma Stem Cells
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research and Development Contracts (N01)
Project #
N01AR022264-000
Application #
6688638
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University of Cincinnati
Department
Type
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Related projects
NIH 2005
N01 AR
Gabapentin in the Treatment of Fibromyalgia-264022264
/ University of Cincinnati
NIH 2004
N01 AR
Innovative Therapies for Rheumatic and Skin Diseases-264022264
/ University of Cincinnati
NIH 2003
N01 AR
Innovative Therapies for Rheumatic and Skin Diseases-N01AR2226
/ University of Cincinnati
NIH 2002
N01 AR
Innovative Therapies for Rheumatic and Skin Diseases-N01AR2226
/ University of Cincinnati
Publications
Arnold, Lesley M; Goldenberg, Don L; Stanford, Sharon B et al.
(2007)
Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial.
Arthritis Rheum 56:1336-44
Comments
Be the first to comment on this grant